Probi

Probi CapEx/OCF

Delisted

The CapEx to Operating Cash Flow Ratio of Probi (PROB.ST) as of Nov 9, 2026 is 63.34 %. In the previous year, CapEx to Operating Cash Flow Ratio was 41.39 % — a change of 53.02% (higher).

CapEx/OCF

63.34 %

YoY

53.02%

Last updated:

CapEx to Operating Cash Flow Ratio of Probi is 2023 63.34 % . CapEx to Operating Cash Flow Ratio of Probi was 2022 41.39 % . It decreases by 53.02% higher compared to the previous year.

The Probi CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2016
21.22 SEK
Jan 1, 2017
18.06 SEK
Jan 1, 2018
10.98 SEK
Jan 1, 2019
20.25 SEK
Jan 1, 2020
30.25 SEK
Jan 1, 2021
27.60 SEK
Jan 1, 2022
41.39 SEK
Jan 1, 2023
63.34 SEK
The Probi CapEx/OCF history
YEARCapEx/OCFYoY
63.34 %+53.02%
41.39 %+49.95%
27.60 %-8.75%
30.25 %+49.42%
20.25 %+84.40%
10.98 %-39.19%
18.06 %-14.93%
21.22 %-32.40%
31.40 %-14.34%
36.65 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Probi Stock analysis

What does Probi do? Probi AB is a Swedish company that specializes in the development and production of probiotic products. Founded in 1991 as a spin-off from Lund Institute of Technology, Probi is now represented in Sweden, the USA, and India with approximately 200 employees. The business model of Probi is based on research and development of probiotic bacterial cultures, as well as marketing probiotic products developed in collaboration with customers and partners. The company's business divisions are divided into probiotic products and research and development. Probiotic products: Probi produces a wide range of probiotic products, including dietary supplements, functional foods, animal feed, and medical devices. These products contain live microorganisms intended to support gut health and strengthen the immune system. Probi works closely with customers and partners to develop tailored solutions. Research and development: An important part of Probi's business is the research and development of probiotic bacterial cultures. Research findings serve as the basis for new products and applications. Probi has its own research department equipped with state-of-the-art laboratory technologies. In addition, Probi collaborates closely with partners from the academic and industrial sectors to explore new technologies and applications. Probi's history originally began in the 1980s at Lund Institute of Technology in Sweden, where the foundation for the development of probiotics was laid. In 1991, Probi was established as a spin-off from the institute, initially focusing on research and development of probiotic bacterial cultures. Over the following years, the company expanded internationally and developed more and more products and applications. Today, Probi is a leading global provider of probiotic products and solutions. Probi's products include probiotic capsules and tablets, probiotic yogurts, beverages, and dietary supplements. These products are intended to stabilize gut flora and strengthen the immune system. Additionally, Probi offers animal feed with probiotic bacterial cultures to promote the health of livestock. An important aspect of Probi is its collaboration with partners and customers. Through these partnerships, innovative products and solutions are developed to meet the needs of customers. Probi works closely with the food industry, healthcare sector, and animal feed industry. The future of Probi looks promising. The company aims to continue developing innovative products and solutions to promote the health of humans and animals. A strong growth strategy will also be pursued to further expand international presence. Probi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Probi stock

CapEx to Operating Cash Flow Ratio of Probi is 63.34 % in 2023.

CapEx to Operating Cash Flow Ratio of Probi changed from 41.39 % to 63.34 %, representing a 53.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Probi since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Probi with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Probi

All Key Metrics — Probi